Your browser doesn't support javascript.
loading
Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events.
Singer, Madeline; Khella, Sami; Bird, Shawn; McIntosh, Paul; Paudyal, Bandhu; Wadhwani, Anil; Quinn, Colin; Karam, Chafic.
Affiliation
  • Singer M; Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Khella S; Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Bird S; Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • McIntosh P; Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Paudyal B; WellSpan Neurology, WellSpan Health, Ephrata, Pennsylvania, USA.
  • Wadhwani A; Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Quinn C; Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Karam C; Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Muscle Nerve ; 69(1): 87-92, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37990374
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activities of Daily Living / Myasthenia Gravis Limits: Humans / Newborn Language: En Journal: Muscle Nerve Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activities of Daily Living / Myasthenia Gravis Limits: Humans / Newborn Language: En Journal: Muscle Nerve Year: 2024 Document type: Article Affiliation country: